STELLANTIS NV/ NL00150001Q9 /
23/05/2024 13:34:12 | Diferencia +0.17 | Volumen | Bid- | Ask- | Capitalización de mecado | Dividendo A. | P/E Ratio |
---|---|---|---|---|---|---|---|
20.54EUR | +0.81% | 14,766 Volumen de negocios: 302,530.27 |
-Volumen de oferta: - | -Tamaño/ Volumen/ Formato de Ask: - | 63.79 mil millonesEUR | 7.55% | 3.43 |
GlobeNewswire
13:45
Victory Square Company Announces Access to Tirzepatide and GLP-1 Injections to its Weight Loss Portf...
Newsfile Corp
13:30
ALX Resources Corp. Amends Hook-Carter Uranium Project Joint Venture Agreement with Denison Mines - ...
GlobeNewswire
13:30
Vic.ai Introduces Superior Performance Analytics for Accounts Payable Teams and Finance Leaders
GlobeNewswire
13:17
CAE, Inc. Falls Over 13% at Open on Impairment Charges, BFA Law Encourages Investors to Contact the ...
GlobeNewswire
13:03
Unicycive Therapeutics to Participate in a Fireside Chat at the Lytham Partners Spring 2024 Investor...
GlobeNewswire
13:00
atai Life Sciences Strengthens Board with Appointment of Two New Independent Directors
GlobeNewswire
13:00
OneMedNet Reports Greater than Five-Fold Expansion of iRWD™ Network and Platform
GlobeNewswire
13:00
Sono-Tek Announces Fiscal Year 2024 Results with Record-Breaking Revenue and Record YOY Backlog
GlobeNewswire
13:00
Hydreight Technologies through its associated Medical network now offer Tirzepatide to Product Offer...
GlobeNewswire
13:00
Leading Proxy Advisory Firm ISS Recommends that Mayfair Gold Shareholders Vote FOR All Company Nomin...
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página